Amir Ashoorzadeh

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 2

Top Topics

Genome Wide Identification

Top Venues

Cancer gene therapy

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander M A van der Wiel, Victoria Jackson-Patel, Raymon Niemans, Ala Yaromina, Emily Liu, Damiënne Marcus, Alexandra M Mowday, Natasja G Lieuwes, Rianne Biemans, Xiaojing Lin, Zhe Fu, Sisira Kumara, Arthur Jochems, Amir Ashoorzadeh, Robert F Anderson, Kevin O Hicks, Matthew R Bull, Maria R Abbattista, Christopher P Guise, Sofie Deschoemaeker, Sophie Thiolloy, Arne Heyerick, Morwena J Solivio, Silvia Balbo, Jeff B Smaill, Jan Theys, Ludwig J Dubois, Adam V Patterson, Philippe Lambin
Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506. Molecular cancer therapeutics 20 (12) (2021)
Dean C Singleton, Alexandra M Mowday, Chris P Guise, Sophie P Syddall, Sally Y Bai, Dan Li, Amir Ashoorzadeh, Jeff B Smaill, William R Wilson, Adam V Patterson
Bioreductive prodrug PR-104 improves the tumour distribution and titre of the nitroreductase-armed oncolytic adenovirus ONYX-411NTR leading to therapeutic benefit. Cancer gene therapy (2021)